CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced Robert McCullough Jr. as the new CEO and Richard Domanik as the new COO in a move to strengthen the Company’s executive, operational and cervical development capabilities. Robert McCullough Jr. is appointed as Chief Executive Officer replacing Dr. Floyd Taub. McCullough has over thirty years of experience both as an operating executive in the health care field and portfolio manager focused on the healthcare sector. McCullough will continue his duties as CFO. Dr. Taub remains as a member of the Company’s Board of Directors.
